Safety, Tolerability, and Efficacy Study of MB07803 Administered to Patients With Type 2 Diabetes Mellitus
Clinical trial NCT00458016 · COMPLETED
Trial details
- NCT number
- NCT00458016
- Sponsor
- Ligand Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2008-03-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.